Cargando…

CTI-2 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Breast Cancer Cells by Modulating MAPK Signaling Pathway

Although some breast cancer patients die due to tumor metastasis rather than from the primary tumor, the molecular mechanism of metastasis remains unclear. Therefore, it is necessary to inhibit breast cancer metastasis during cancer treatment. In this case, after designing and synthesizing CTI-2, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Junfeng, Han, Wenzhao, Meng, Fanwei, Guo, Feng, Wang, Yuhong, Wang, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622910/ https://www.ncbi.nlm.nih.gov/pubmed/34830111 http://dx.doi.org/10.3390/ijms222212229

Ejemplares similares

A New TGF-β1 Inhibitor, CTI-82, Antagonizes Epithelial–Mesenchymal Transition through Inhibition of Phospho-SMAD2/3 and Phospho-ERK
por: Jeong, Ji-Hoon, et al.
Publicado: (2020)

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
por: Wang, Changli, et al.
Publicado: (2012)

Targeting self-assembled F127-peptide polymer with pH sensitivity for release of anticancer drugs
por: Han, Wenzhao, et al.
Publicado: (2021)

CTI special feature on inflammatory diseases: a translational perspective
por: Wong, Connie HY
Publicado: (2016)

CTI special feature on innate immune responses and vaccine design
por: Sundling, Christopher, et al.
Publicado: (2016)

MiR-22 suppresses epithelial–mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop
por: Xu, Mingjie, et al.
Publicado: (2018)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

Circ_001042 Inhibits TGF-β1/P38 MAPK Signaling Axis-Mediated Epithelial-Mesenchymal Transition and Metastasis in Lung Adenocarcinoma
por: Zhou, Lixia, et al.
Publicado: (2022)

Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis
por: Du, Liang, et al.
Publicado: (2017)

Cigarette smoke induced urocystic epithelial mesenchymal transition via MAPK pathways
por: Yu, Dexin, et al.
Publicado: (2017)

MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis
por: Cai, Hong-Ke, et al.
Publicado: (2017)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway
por: Wang, Lishan, et al.
Publicado: (2016)

Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014)

MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Li, Jiazhi, et al.
Publicado: (2018)

Tecnologías para la integración de sistemas telefónicos e informáticos "CTI" /
por: Hernández Jiménez, Gabino
Publicado: (2006)

229 Incidence of Allergy to Artemisia Vulgaris and Salsola Kali in Sabzevar cCty
por: Matloobi, Zahra
Publicado: (2012)

Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma
por: Chen, Lu, et al.
Publicado: (2019)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis
por: Huang, Yuting, et al.
Publicado: (2014)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis via the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma
por: Wu, Qiuyu, et al.
Publicado: (2022)

Amyloid β precursor protein silencing attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway
por: Xu, Jin, et al.
Publicado: (2019)

Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras/MAPK signaling pathway and epithelial-to-mesenchymal transition
por: Mo, Shutian, et al.
Publicado: (2022)

Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma
por: Chen, Jiang, et al.
Publicado: (2019)

Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness
por: Li, Xiao, et al.
Publicado: (2017)

RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
por: Hui, Ke, et al.
Publicado: (2017)

miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition
por: Wang, Lin, et al.
Publicado: (2015)

The Role of the p38 MAPK Signaling Pathway in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Renal Tubular Epithelial Cells
por: Lv, Zhi-Mei, et al.
Publicado: (2011)

Matrine suppresses breast cancer metastasis by targeting ITGB1 and inhibiting epithelial-to-mesenchymal transition
por: Ren, Lili, et al.
Publicado: (2020)

Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis
por: Yao, Ting, et al.
Publicado: (2022)

Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway
por: Xu, Lijun, et al.
Publicado: (2014)

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition
por: Cui, Yuehong, et al.
Publicado: (2016)

Retracted: Circ_001042 Inhibits TGF-β1/P38 MAPK Signaling Axis-Mediated Epithelial-Mesenchymal Transition and Metastasis in Lung Adenocarcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retraction Notice to: MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Li, Jiazhi, et al.
Publicado: (2022)

Targeting BMI-1-mediated epithelial–mesenchymal transition to inhibit colorectal cancer liver metastasis
por: Xu, Zhiyao, et al.
Publicado: (2021)

Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition
por: Han, Xu, et al.
Publicado: (2019)

Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process
por: Dana, Paweena, et al.
Publicado: (2017)

Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer
por: Chen, Dong-liang, et al.
Publicado: (2017)

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs
por: Axiak, Sandra M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v72gvvb2dmrt5rmb6qnfuaoofl